|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01518 NC HEALTHCARE
Nominal 
0.249 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 248,958 | -18.248% | 600,099 | 846,496 | 933,073 | 636,459 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,223) | -73.878% | (5,846) | (5,802) | (32,432) | (290,202) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 566 | -37.870% | 1,164 | 2,265 | (80) | (27) | |
| Profit / (Loss) before Taxation | (95,544) | 132.535% | (74,542) | 141,544 | 166,142 | (289,853) | |
| Taxation | (5,895) | -66.731% | (24,567) | (47,762) | (34,053) | (1,720) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 16,480 | -- | (16,201) | (46,404) | (47,925) | (6,161) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (84,959) | 30.237% | (115,310) | 47,378 | 84,164 | (297,734) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 3,474 | 82.458% | 4,703 | 2,691 | 5,587 | 3,317 |
| Depreciation & Amortisation | 21,662 | -13.463% | 47,675 | 51,697 | 59,982 | 70,249 |
| Directors' Emoluments | -- | -- | -- | 7,033 | 6,334 | 5,852 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -18.000 | 28.571% | -24.000 | 10.000 | 17.000 | -62.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 2.039 | 3.428 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 20.389% | 20.164% | -- |
| Cash flow per share ($) | -- | -- | 0.037 | 0.281 | 0.329 | 0.158 |
| NBV per share ($) | 0.702 | -- | 0.875 | 1.130 | 1.066 | 0.894 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -84,959 |
| %Change | 30.237% |
| EPS / (LPS) | RMB -0.180 |
| NBV Per Share (¥) | RMB 0.702 |